[ad_1]
Moderna CEO Stephane Bancel recently said the company could have results on its coronavirus vaccine candidate by November, according to a news report.
As of Wednesday, the company had enrolled about 84% of all participants for the COVE phase 3 study of its candidate vaccine, mRNA-1273, at 100 research sites. An estimated 28% of these participants come from diverse communities, a company update said.
According to a report by The Boston Globe, Bancel said Moderna expected to see results in October, but a recent drop in the national average number of cases created difficulties in reaching the number of infections among trial participants needed to see if the candidate vaccine outperforms the placebo. .
Moderna CEO Stephane Bancel recently said the company could have results on its coronavirus vaccine candidate by November, according to a report. (iStock)
If the infection rate continues to fall, Bancel said the reading could occur in December, the outlet wrote.
SCIENTISTS MAY KNOW WHERE THE CORONAVIRUS ORIGINATED, STUDY SAYS
Meanwhile, Albert Bourla, CEO of Pfizer, said there is a “good chance” that Pfizer will learn of the safety and efficacy results as of late October, The Boston Globe wrote, citing comments made Sunday in “Face the Nation” by CBS.
FAN AT JEFS GAME ‘PRESENTED POSITIVE’ FOR CORONAVIRUS, SAYS THE TEAM
Bancel reportedly said it “doesn’t matter” if Pfizer announces its efficacy results first, adding that a pharmaceutical company cannot supply enough vaccines to stop the global pandemic.
Moderna posted the protocol online for its last-stage test on Thursday, which consists of a 135-page document. According to the New York Times, scientists have called for protocols to be shared so that other experts can evaluate them.
GLASSES MAY BE A ‘PROTECTIVE FACTOR’ AGAINST CORONAVIRUS, RESEARCHERS SAY
Meanwhile, the Food and Drug Administration has previously said that it expects a “COVID-19 vaccine to prevent the disease or lessen its severity in at least 50% of vaccinated people.”
If Moderna reaches this benchmark, Bancel would have said it would quickly seek emergency approval to begin distribution.
“At that point, we can ship whatever we have in store” to the federal government, Bancel said, according to The Boston Globe.
CLICK HERE TO SEE THE FOX NEWS APP
